News Daily News Small Fraction of STEMI Patients With Shock Meet DanGer Criteria Caitlin E. Cox October 11, 2024
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Daily News Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups Michael O'Riordan May 09, 2023
News Conference News ACC 2023 Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2 Michael O'Riordan March 09, 2023
News Daily News Anatomic Disease After PCI Linked With Worse Outcomes: VA CART Michael O'Riordan December 22, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News Outpatient PCI Takes Hold in US Practice, Muddying Volume Trends Caitlin E. Cox July 26, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Daily News Cost-effectiveness Favors Anatomic Over Functional Testing for Stable Chest Pain Todd Neale December 18, 2020
News Daily News PCI Volumes Rise in US and Japan, but for Different Reasons Michael O'Riordan September 14, 2020
News Daily News PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching Shelley Wood February 19, 2020
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Conference News ACC 2019 High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI Michael O'Riordan March 21, 2019
News Conference News ESC 2018 BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease Todd Neale August 28, 2018
News Conference News ESC 2018 FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice Todd Neale August 26, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017